Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma
Abstract The emergence of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Biomarkers of the therapeutic efficacy of ICIs have been extensively investigated. In this study, we aimed to analyze whether mo...
Saved in:
Main Authors: | Hiroe Tada, Hideyuki Takahashi, Reika Kawabata-Iwakawa, Yurino Nagata, Miho Uchida, Masato Shino, Shota Ida, Ikko Mito, Toshiyuki Matsuyama, Kazuaki Chikamatsu |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/b28b2d63a4804c69a542aee6503715fb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
by: Ikko Mito, et al.
Published: (2021) -
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma
by: Hideyuki Takahashi, et al.
Published: (2021) -
Diffuse large B-cell lymphoma of the pterygopalatine fossa with multiple cranial nerve palsies
by: Shota Ida, et al.
Published: (2021) -
Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab
by: Kiyoshi Minohara, et al.
Published: (2021) -
IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses
by: Taylor A. Harper, et al.
Published: (2021)